Category: Emergency Medicine

JC: Spot the Difference, what can we do about petechiae? St Emlyn’s

Back in 2013, I wrote a post here on petechiae in well kids; it received a phenomenal number of views for reasons I don’t quite understand (I think it ended up as a link somewhere

October 2020

October 2020 round up podcast

October was a busy month with a strong theme of trauma and coagulopathy. Iain and Simon got together to podcast the highlights which you can listen to on the link below, or even better subscribe

Why infection control failures might kill your patients and colleagues. St Emlyn’s

This blog is based upon a short lecture given by Simon Mardel OBE (1,2). He is an emergency physician who has extensive experience in humanitarian work. He has worked in many infectious disease outbreaks around

JC: Early plasma use in traumatic brain injury. St Emlyn’s

There seems to be a lot of really interesting papers on Traumatic Brain Injury (TBI) this year. A welcome relief from COVID 19 perhaps but also a reminder that other pathologies exist and that TBI

JC: Finger on the Pulse?

If you’re an avid follower of FOAM, you’ll have seen many assertions that manual pulse checks by healthcare providers during cardiac arrest are pretty unreliable at best. The most commonly advocated alternatives are EtCO2 increase

JC: Should we rubber STAAMP prehospital TXA?

This post is co-published with our friends at REBEL EM. Background: It almost seems that when it comes to the use of the antifibrinolytic agent tranexamic acid (TXA) in trauma, one argument has just been

JC: Blood Products in Trauma – What’s the Best (I)TACTIC?

Bleeding trauma patients present a couple of challenges to us in the Emergency Department. Increasingly, our aging population continues to engage in energetic daily pursuits while increasing numbers are prescribed newer direct oral anticoagulant treatments

September Round Up Podcast

Welcome to our audio round up of everything on the blog during September. It’s been a relatively quiet on the blog post this month, but we chat through not only blogposts on the REMAP-CAP trial,

VTE and COVID-19: Would you like to know more?

That’s a leading question. Of course you would.  Who wouldn’t want to know more about a disease that has killed >1 million people to date, worldwide. Who wouldn’t want to know more about the thromboembolic risk associated

JC: Hydroxychloroquine in the the treatment of hospitalised COVID19 patients.

We previously covered the RECOVERY trial press release on the use of HCQ for hospitalised patients with COVID19. This is a UK based platform trial (more on this later) looking at patients admitted to hospital

Translate »